Verastem | VSTM - Należności Handlowe





Należności Handlowe Zmiana Data
AbbVie USD 12.59B 180M 2025-12
Alaunos Therapeutics USD 2K 0 2025-06
AstraZeneca USD 17.88B 1.17B 2026-03
Curis USD 2.55M 400K 2024-06
Cytokinetics USD 6.83M 10.94M 2026-03
Gilead Sciences USD 4.74B 172M 2026-03
Incyte USD 1.05B 27.09M 2026-03
Laboratory Of America USD 2.45B 189.8M 2026-03
Novartis USD 9.6B 2.69B 2026-03
Pfizer USD 16.17B 332M 2026-03
Roche Holding CHF 11.9B 460M 2025-12
TG Therapeutics USD 392.05M 86.42M 2026-03
Verastem USD 9.01M 8.81M 2025-12